Drug Discovery Centers

Chemical Biology Consortium Sweden

Therapeutic Approaches: Small Molecules

Therapeutic Areas of Expertise: Immunology, Infectious Diseases, Metabolic Disorders, Oncology, Pain

Center/Program Highlights:CBCS is established as a non-profit national infrastructure dedicated to the advancement of chemical biology as a critical component of biomedical research in Sweden. The consortium aims to assist and collaborate with cutting-edge academic research for the discovery and development of chemical probes (small organic molecules) with which to unravel new knowledge related to protein and cellular function and signaling. CBCS will supply expertise within assay development, high-throughput and high-content screening, development of molecular libraries, computational chemistry, medicinal chemistry optimisation, targe identification/validation, cheminformatics and in vitro pharmaceutical profiling to academic researchers at Swedish universities.

By helping to bring together people, ideas and technology from all aspects of biomedical research in Swedish academia, CBCS’s envisions to become an internationally recognized contributor to the advancement of medical science.

Sources of Funding: Federal/State, University